Radiforce RX240
System, Image Processing, Radiological. 510(k) K113844, from Eizo Nanao Corporation (Ishikawa, JP). Product code LLZ, class 2.
As of Nov 21, 2026, K113844 is an FDA 510(k) held by Eizo Nanao Corporation, substantially equivalent on Feb 27, 2012 after 61 days, with no recalls tied to it in FDA's recall database.
- Review time: 61 days
- Recalls: 0
- Cited as a predicate by: 3 devices
The RadiForce RX240 is intended to be used in displaying and viewing digital images for diagnosis of X-ray or MRI, etc. by trained medical practitioners. The device does not support the display of mammography images for diagnosis.
- Color Lcd Monitor, Model Radiforce RS210K092613 · Eizo Nanao Corporation · Mar 3, 2010
- RadiForce MX317WK233465 · Eizo Corporation · Dec 21, 2023
- JUSHA-C23C LCD MonitorK151861 · Nanjing Jusha Display Technology Co., Ltd. · Sep 10, 2015
- 2MP Color LCD Monitor, RadiForce RS240K150106 · Eizo Corporation · Apr 3, 2015
- 3D Anatomical ModelK262132 · The Jacobs Institute · Nov 5, 2026
- LiLi DICOM Viewer (LiLi )K260454 · Elevate Imaging, Inc. · Nov 4, 2026
- Vitrea Advanced Visualization, Version 7.16K263648 · Canon Medical Informatics, Inc. · Oct 29, 2026
- MIM – KineticIDK261763 · Mim Software, Inc. · Oct 26, 2026
- PV-iCurve ProK261531 · Perception Vision Medical Technology Co., Ltd. · Oct 21, 2026
- Eden PACSK261788 · Higia., Inc. d/b/a Eden · Oct 21, 2026
- Syngo Carbon Space (VA4)K263048 · Siemens Healthineers AG · Sep 29, 2026
- Syneris PACS v.1.0.1.0K261874 · Syneris · Sep 23, 2026
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Dec 28, 2011
- Review panel
- Radiology
- Regulation
- 21 CFR 892.2050
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files